For instance, PI3K activation inhibits anti-cancer capacities in T-cells to promote tumorigenesis, and PI3K inhibition can mitigate the recruitment of myeloid cells to the tumor microenvironment that otherwise promote tumor growth [64–66]. The gene discussed is PIK3CG; the disease is cancer.